Orange Book product · Generic (ANDA)
FELODIPINE
FELODIPINE
At a glance
Aug 19, 2016
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Aug 19, 2016
10 yr ago
Today
Pharmaceutical detail
Active ingredient
FELODIPINE
Strength
2.5MG
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
TE code
Not listed
Application
ANDA 203983
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of FELODIPINE
- 1994PLENDILBrand (NDA)
NDA 019834 · ASTRAZENECA
- 2019FELODIPINEGeneric (ANDA)
ANDA 204800 · YUNG SHIN PHARM
- 2018FELODIPINEGeneric (ANDA)
ANDA 210847 · YILING
- 2015FELODIPINEGeneric (ANDA)
ANDA 203032 · ORBION PHARMS
- 2013FELODIPINEGeneric (ANDA)
ANDA 091200 · SUN PHARM INDS LTD
- 2013FELODIPINEGeneric (ANDA)
ANDA 201964 · HERITAGE
- 2013FELODIPINEGeneric (ANDA)
ANDA 203417 · AUROBINDO PHARMA LTD
- 2012FELODIPINEGeneric (ANDA)
ANDA 091484 · WOCKHARDT BIO AG
- 2011FELODIPINEGeneric (ANDA)
ANDA 202170 · TORRENT PHARMS LTD
- 2011FELODIPINEGeneric (ANDA)
ANDA 200815 · PH HEALTH
- 2010FELODIPINEGeneric (ANDA)
ANDA 090365 · GLENMARK PHARMS LTD
- 2008FELODIPINEGeneric (ANDA)
ANDA 078855 · MYLAN
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
